An ancient virus that infected our ancestors tens of millions of years ago may be helping to fuel cancer today, according to a fascinating new study in Science Advances. Targeting these viral remnants still lingering in our DNA could lead to more effective cancer treatment with fewer side effects, the researchers said. The study “gives …
This transcript has been edited for clarity. Hello. I’m Dr Maurie Markman, from City of Hope. I wanted to briefly discuss what I consider to be not only a critically important trial but also a representative of an incredibly important, underrepresented type of trial as we move forward in the oncology arena. I cannot overstate …
BERLIN — To date, mRNA vaccines have had their largest global presence in combating the COVID-19 pandemic. Intensive research is underway on many other potential applications for this vaccine technology, which suggests a promising future. Martina Prelog, MD, a pediatric and adolescent medicine specialist at the University Hospital of Würzburg in Germany, reported on the …
Hello. I’m David Kerr, professor of cancer medicine, from University of Oxford. I’d like to talk today about a nice editorial in Lancet Oncology written by Grimes and O’Riordan from Trinity in Dublin, entitled, “Quackery: Starving Cancer and Other Dangerous Dietary Misconceptions.” I’ll address what these misconceptions are, but perhaps also think about whether there …
This transcript has been edited for clarity. Hello. I’m Dr Maurie Markman, from City of Hope. I wanted to briefly discuss a very interesting, important, but also discouraging paper and analysis. This paper was recently published online in JAMA Otolaryngology – Head & Neck Surgery on August 31, 2023. The paper is entitled, “Deciphering Knowledge …
TOPLINE: The vaccine Cervarix was effective in protecting women from cervical cancer when administered between ages 12 and 13 years, according to a new study published in Journal of the National Cancer Institute. METHODOLOGY: Cervical cancer is the fourth most common cancer among women worldwide. Programs to provide Cervarix, a bivalent vaccine, began in the …
When the American Cancer Society recently unveiled changes to its lung cancer screening guidance, the aim was to remove barriers to screening and catch more cancers in high-risk people earlier. Although the lung cancer death rate has declined significantly over the past few decades, lung cancer remains the leading cause of cancer deaths worldwide. Detecting …
There’s a long-standing concern among oncologists that many women with ductal carcinoma in situ (DCIS), a potential precursor to invasive breast cancer, receive more treatment than they need. The potential for overtreatment largely revolves around the extent of surgery and the use of radiation. Using the Oncotype DX Breast DCIS Score test, a laboratory test that …